There are over 1 billion people currently in retirement. New types of financial institutions are evolving to satisfy the needs of the aging population. Investment banks, pension funds, and insurance companies are developing new business models, and are using AI to improve the quality of the analytics used to formulate them. In the near future, the synergy between innovative AI and wealth management will lead to the creation of a new financial institutions optimized for the aging population and age-friendly Longevity banks will make banking easier and safer for seniors. Over 150 financial companies are already developing innovative WealthTech and AgeTech products and services and AI is central to the process.

There are over 1 billion people currently in retirement. New types of financial institutions are evolving to satisfy the needs of the aging population. Investment banks, pension funds, and insurance companies are developing new business models, and are using AI to improve the quality of the analytics used to formulate them. In the near future, the synergy between innovative AI and wealth management will lead to the creation of a new financial institutions optimized for the aging population and age-friendly Longevity banks will make banking easier and safer for seniors. Over 150 financial companies are already developing innovative WealthTech and AgeTech products and services and AI is central to the process.

AI for Longevity has more potential to increase healthy Longevity in the short term than any other sector. The application of AI for Longevity will bring the greatest real-world benefits and will be the main driver of progress in the widespread extension of healthy Longevity. The global spending power of people aged 60 and over is anticipated to reach $15 trillion annually by 2020. The Longevity industry will dwarf all other industries in both size and market capitalization, reshape the global financial system, and disrupt the business models of pension funds, insurance companies, investment banks, and entire national economies. Longevity has become a recurring topic in analytical reports from leading financial institutions such as CitiBank, UBS Group, Julius Baer, and Barclays.

AI for Longevity has more potential to increase healthy Longevity in the short term than any other sector. The application of AI for Longevity will bring the greatest real-world benefits and will be the main driver of progress in the widespread extension of healthy Longevity. The global spending power of people aged 60 and over is anticipated to reach $15 trillion annually by 2020. The Longevity industry will dwarf all other industries in both size and market capitalization, reshape the global financial system, and disrupt the business models of pension funds, insurance companies, investment banks, and entire national economies. Longevity has become a recurring topic in analytical reports from leading financial institutions such as CitiBank, UBS Group, Julius Baer, and Barclays.

AI for Longevity has more potential to increase healthy Longevity in the short term than any other sector. The application of AI for Longevity will bring the greatest real-world benefits and will be the main driver of progress in the widespread extension of healthy Longevity. The global spending power of people aged 60 and over is anticipated to reach $15 trillion annually by 2020. The Longevity industry will dwarf all other industries in both size and market capitalization, reshape the global financial system, and disrupt the business models of pension funds, insurance companies, investment banks, and entire national economies. Longevity has become a recurring topic in analytical reports from leading financial institutions such as CitiBank, UBS Group, Julius Baer, and Barclays.

There's been significant growth in the AI for Drug Discovery sector this year. In the last quarter, the number of R&D centers increased by 5, companies increased by 20, collaborations increased by 30, and investors increased by 50. There are now 400 investors investing in AI for Drug Discovery including Google Ventures, Tencent, WuXi, Andreessen Horowitz, Khosla Ventures, and Sequoia Ventures. This week, Deep Knowledge Analytics Pharma Division published Landscape of AI for Drug Discovery and Advanced R&D Q2 2019. This report is the most comprehensive analytical report on the AI for Drug Discovery sector to date.

In our new book Longevity Industry 1.0 - Defining the Biggest and Most Complex Industry in Human History, Dmitry Kaminskiy and I distill the complex assembly of deep market intelligence and industry knowledge that we have developed over the past five years. We present the full-scope of the Global Longevity Industry showing exactly how we managed to define this complex and multidimensional industry and how we created a tangible framework for systematization and forecasting. This article includes the preface and the foreword from our book. Every cause of death is, in principle, preventable. I became aware of this in the 1990s and since then I have been following aging research very closely.